1-10 of 10
Catherine P. Lavau
Close
Sort by
Journal Articles

A SIX1/EYA2 Inhibitor Impairs CALM-AF10 and Jurkat Leukemia Cell Proliferation

Waitman Kurt Aumann, Catherine P. Lavau, Dongdong Julie Chen, Amanda E. Conway, Heide Ford, Daniel S. Wechsler
Journal: Blood
Blood (2021) 138 (Supplement 1): 4331.
https://doi.org/10.1182/blood-2021-154156
Published: 2021
Journal Articles

The SIX1 homeobox Gene Is a Novel Therapeutic Target in CALM-AF10 Leukemogenesis

Waitman K. Aumann, MDMS, Catherine P. Lavau, DVM, PhD, Amanda Harrington, MD, Donald Tope, Amanda E. Conway, PhD, Hengbo Zhou, PhD, Heide Ford, PhD, Daniel S. Wechsler, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-140754
Published: 2020
Journal Articles

SIX1 Is a Novel Effector Gene in CALM-AF10 Leukemia

Waitman K. Aumann, MDMS, Catherine P. Lavau, DVM, PhD, Amanda Harrington, MD, Amanda E. Conway, PhD, Daniel S. Wechsler, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5035.
https://doi.org/10.1182/blood-2019-130178
Published: 2019
Journal Articles

The SQSTM1-NUP214 Fusion Protein Cooperates with Crm1 to Activate Hoxa Genes and Drives Leukemogenesis in Mice

Waitman K. Aumann, MDMS, Sei-Gyung K. Sze, MD, Veerain Gupta, Katelyn Ripple, Sarah Port, Ralph Kehlenbach, PhD, Daniel S. Wechsler, MD PhD, Catherine P. Lavau, DVM, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1434.
https://doi.org/10.1182/blood-2019-130530
Published: 2019
Journal Articles

A Role for the CRM1 Nuclear Export Receptor in HOXA Gene Deregulation and CALM-AF10 Leukemogenesis

Waitman K. Aumann, MD, Jessica L. Heath, MD, Sei-Gyung K. Sze, MD, Amanda E. Conway, PhD, Catherine P. Lavau, DVM, PhD, Daniel S. Wechsler, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 369.
https://doi.org/10.1182/blood.V130.Suppl_1.369.369
Published: 2017
Journal Articles

The CRM1 Nuclear Export Receptor Activates HOXA Gene Expression in Leukemogenesis

Catherine P Lavau, DVM, PhD, Jessica L Heath, MD, William H Lee, Amanda E Conway, PhD, Daniel S Wechsler, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2190.
https://doi.org/10.1182/blood.V124.21.2190.2190
Published: 2014
Journal Articles

A CALM-derived nuclear export signal is essential for CALM-AF10–mediated leukemogenesis

Amanda E. Conway, Paula B. Scotland, Catherine P. Lavau, Daniel S. Wechsler
Journal: Blood
Blood (2013) 121 (23): 4758–4768.
https://doi.org/10.1182/blood-2012-06-435792
Published: 2013
Includes: Supplemental data
Journal Articles

Iron Deprivation Impairs Proliferation of CALM-AF10 leukemia Cells in Vitro and in Vivo

Jessica L Heath, MD, Joshua Weiss, Paula B. Scotland, PhD, Catherine P. Lavau, DVM, PhD, Daniel S. Wechsler, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1386.
https://doi.org/10.1182/blood.V120.21.1386.1386
Published: 2012
Journal Articles

CALM Insufficiency Impairs Leukemia Cell Proliferation by Limiting Iron Uptake

Catherine P. Lavau, DVM, PhD, Jessica L Heath, MD, Paula B. Scotland, PhD, Daniel S. Wechsler, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1478.
https://doi.org/10.1182/blood.V118.21.1478.1478
Published: 2011
Journal Articles

FLT3 Signaling Is Not Necessary to the Leukemogenic Properties of MLL Fusion Genes in a Murine Model.

Catherine P. Lavau, DVM, PhD, Marta Libura, MD, PhD, Stéphanie Albouhair
Journal: Blood
Blood (2004) 104 (11): 3491.
https://doi.org/10.1182/blood.V104.11.3491.3491
Published: 2004